Title: ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
Journal: Journal of clinical pharmacology 20090101
Title: Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
Journal: American heart journal 20090101
Title: Treatment of hyperlipidaemia with fenofibrate and related fibrates.
Journal: Expert opinion on investigational drugs 20081001
Title: Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
Journal: Clinical drug investigation 20080101
Title: Xudan Wei, et al. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry. Biomed Chromatogr. 2017 Apr;31(4).